EMA – The Committee for Medicinal Products for Human Use (CHMP) for the medicinal product Nustendi adopted a new indication as follows: Cardiovascular disease
21/03/2024
Leggi
Giallo
Le Breaking News di colore giallo sono relative a notizie dalle agenzie regolatorie o da società scientifiche: nuovi farmaci, ritiri, eventi avversi rilevanti…
EMA – The Committee for Medicinal Products for Human Use (CHMP) for the medicinal product Nilemdo adopted a new indication as follows: Cardiovascular disease
21/03/2024
Leggi
EMA – The Committee for Medicinal Products for Human Use (CHMP) recommended granting a marketing authorisation for Awiqli (insulin icodec) for the treatment of diabetes mellitus in adults
21/03/2024
Leggi
FDA clears first over-the-counter continuous glucose monitor: Dexcom Stelo Glucose Biosensor System
05/03/2024
Leggi
Wegovy (semaglutide) injection: FDA approves first treatment to reduce risk of serious heart problems specifically in adults with obesity or overweight
08/03/2024
Leggi
REZDIFFRA (resmetirom): FDA approves first treatment for patients with liver scarring due to fatty liver disease
14/03/2024
Leggi
AIFA – Classe di rimborsabilita’ A: formulazione mensile PRALUENT (alirocumab) 300 mg soluzione iniettabile in penna pre-riempita (1 penna) e 300 mg soluzione iniettabile in penna pre-riempita (3 penne)
14/03/2024
Leggi
AIFA – PRALUENT (alirocumab): il registro di monitoraggio è aggiornato e convertito in piano terapeutico web-based
14/03/2024
Leggi